Showing 1 - 3 results of 3 for search 'Luis Fayad', query time: 0.04s
Refine Results
-
1
-
2
P1092: A PHASE II INVESTIGATOR INITIATED STUDY OF ACALABRUTINIB, LENALIDOMIDE AND RITUXIMAB (AR2) IN PATIENTS WITH PREVIOUSLY UNTREATED HIGH TUMOR BURDEN FOLLICULAR LYMPHOMA by Paolo Strati, Lei Feng, Jason Westin, Ranjit Nair, Sushanth Gouni, Luis Fayad, Maria Rodriguez, Dai Chihara, Luis Malpica, Raphael Steiner, Mariana Gallardo, Loretta J. Nastoupil, Sattva Neelapu
Published 2023-08-01
Article -
3
The iR2 regimen (ibrutinib plus lenalidomide and rituximab) for relapsed/refractory DLBCL: a multicentre, non-randomised, open-label phase 2 studyResearch in context by Radhakrishnan Ramchandren, Peter Johnson, Nilanjan Ghosh, Jia Ruan, Kirit M. Ardeshna, Roderick Johnson, Gregor Verhoef, David Cunningham, Sven de Vos, Shireen Kassam, Luis Fayad, John Radford, Sarah Bailly, Fritz Offner, David Morgan, Javier Munoz, Jerry Ping, Edith Szafer-Glusman, Karl Eckert, Jutta K. Neuenburg, Andre Goy
Published 2023-02-01
Article